Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study
To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized...
Saved in:
Published in | Scientific reports Vol. 15; no. 1; pp. 9942 - 9 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
22.03.2025
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized to differentiate between MIBC and NMIBC based on three-channel image inputs, including original T2WI images, segmented bladder, and regions of interest. Inception V3 was employed for model construction. The accuracy, sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) for predicting MIBC by DL model were 92.4%, 94.7%, 91.5%, 81.8% and 97.7% in the validation set and 92.1%, 86.8%, 94.6%, 88.5% and 93.8% in the internal test set. In the external test set, these values were 81.6%, 57.1%, 87.1%, 50.0% and 90.0%. Additionally, the accuracy, SN, SP, PPV, and NPV for predicting MIBC were 93.5%, 100%, 93.4%, 11.1%, and 100% in VI-RADS 2; 80.0%, 66.7%, 87.2%, 73.7% and 82.9% in VI-RADS 3; 90.3%, 91.7%, 85.7%, 95.7%, 75.0% in VI-RADS 4. The accuracy, SN, and PPV were 93.9%, 93.9%, and 100% in VI-RADS 5. The DL model based on T2WI can effectively predict MIBC and serve as a valuable complement to VI-RADS 3. |
---|---|
AbstractList | To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized to differentiate between MIBC and NMIBC based on three-channel image inputs, including original T2WI images, segmented bladder, and regions of interest. Inception V3 was employed for model construction. The accuracy, sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) for predicting MIBC by DL model were 92.4%, 94.7%, 91.5%, 81.8% and 97.7% in the validation set and 92.1%, 86.8%, 94.6%, 88.5% and 93.8% in the internal test set. In the external test set, these values were 81.6%, 57.1%, 87.1%, 50.0% and 90.0%. Additionally, the accuracy, SN, SP, PPV, and NPV for predicting MIBC were 93.5%, 100%, 93.4%, 11.1%, and 100% in VI-RADS 2; 80.0%, 66.7%, 87.2%, 73.7% and 82.9% in VI-RADS 3; 90.3%, 91.7%, 85.7%, 95.7%, 75.0% in VI-RADS 4. The accuracy, SN, and PPV were 93.9%, 93.9%, and 100% in VI-RADS 5. The DL model based on T2WI can effectively predict MIBC and serve as a valuable complement to VI-RADS 3. Abstract To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized to differentiate between MIBC and NMIBC based on three-channel image inputs, including original T2WI images, segmented bladder, and regions of interest. Inception V3 was employed for model construction. The accuracy, sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) for predicting MIBC by DL model were 92.4%, 94.7%, 91.5%, 81.8% and 97.7% in the validation set and 92.1%, 86.8%, 94.6%, 88.5% and 93.8% in the internal test set. In the external test set, these values were 81.6%, 57.1%, 87.1%, 50.0% and 90.0%. Additionally, the accuracy, SN, SP, PPV, and NPV for predicting MIBC were 93.5%, 100%, 93.4%, 11.1%, and 100% in VI-RADS 2; 80.0%, 66.7%, 87.2%, 73.7% and 82.9% in VI-RADS 3; 90.3%, 91.7%, 85.7%, 95.7%, 75.0% in VI-RADS 4. The accuracy, SN, and PPV were 93.9%, 93.9%, and 100% in VI-RADS 5. The DL model based on T2WI can effectively predict MIBC and serve as a valuable complement to VI-RADS 3. To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized to differentiate between MIBC and NMIBC based on three-channel image inputs, including original T2WI images, segmented bladder, and regions of interest. Inception V3 was employed for model construction. The accuracy, sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) for predicting MIBC by DL model were 92.4%, 94.7%, 91.5%, 81.8% and 97.7% in the validation set and 92.1%, 86.8%, 94.6%, 88.5% and 93.8% in the internal test set. In the external test set, these values were 81.6%, 57.1%, 87.1%, 50.0% and 90.0%. Additionally, the accuracy, SN, SP, PPV, and NPV for predicting MIBC were 93.5%, 100%, 93.4%, 11.1%, and 100% in VI-RADS 2; 80.0%, 66.7%, 87.2%, 73.7% and 82.9% in VI-RADS 3; 90.3%, 91.7%, 85.7%, 95.7%, 75.0% in VI-RADS 4. The accuracy, SN, and PPV were 93.9%, 93.9%, and 100% in VI-RADS 5. The DL model based on T2WI can effectively predict MIBC and serve as a valuable complement to VI-RADS 3.To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our center and 38 patients in external centers were collected from 2012 to 2023 to construct the DL model. In this study, the DL model was utilized to differentiate between MIBC and NMIBC based on three-channel image inputs, including original T2WI images, segmented bladder, and regions of interest. Inception V3 was employed for model construction. The accuracy, sensitivity (SN), specificity (SP), positive predictive value (PPV) and negative predictive value (NPV) for predicting MIBC by DL model were 92.4%, 94.7%, 91.5%, 81.8% and 97.7% in the validation set and 92.1%, 86.8%, 94.6%, 88.5% and 93.8% in the internal test set. In the external test set, these values were 81.6%, 57.1%, 87.1%, 50.0% and 90.0%. Additionally, the accuracy, SN, SP, PPV, and NPV for predicting MIBC were 93.5%, 100%, 93.4%, 11.1%, and 100% in VI-RADS 2; 80.0%, 66.7%, 87.2%, 73.7% and 82.9% in VI-RADS 3; 90.3%, 91.7%, 85.7%, 95.7%, 75.0% in VI-RADS 4. The accuracy, SN, and PPV were 93.9%, 93.9%, and 100% in VI-RADS 5. The DL model based on T2WI can effectively predict MIBC and serve as a valuable complement to VI-RADS 3. |
ArticleNumber | 9942 |
Author | Li, Kai Cao, Qiang Li, Pengchao Shao, Qiang Fang, Xiangming Lu, Qiang Cai, Lingkai Chen, Chunxiao Wang, Gongcheng Yang, Xiao Zhuang, Juntao Zou, Yuan Fu, Xue Wu, Qikai Liu, Peikun Sun, Xueying Yuan, Baorui Yu, Jie Yu, Ruixi |
Author_xml | – sequence: 1 givenname: Lingkai surname: Cai fullname: Cai, Lingkai organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Department of Urology, Wuxi Medical Center of Nanjing Medical University – sequence: 2 givenname: Xiao surname: Yang fullname: Yang, Xiao organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 3 givenname: Jie surname: Yu fullname: Yu, Jie organization: Department of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics – sequence: 4 givenname: Qiang surname: Shao fullname: Shao, Qiang organization: Department of Urology, Suzhou Hospital Affiliated of Nanjing Medical University – sequence: 5 givenname: Gongcheng surname: Wang fullname: Wang, Gongcheng organization: Department of Urology, The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University – sequence: 6 givenname: Baorui surname: Yuan fullname: Yuan, Baorui organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 7 givenname: Juntao surname: Zhuang fullname: Zhuang, Juntao organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 8 givenname: Kai surname: Li fullname: Li, Kai organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 9 givenname: Qikai surname: Wu fullname: Wu, Qikai organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 10 givenname: Peikun surname: Liu fullname: Liu, Peikun organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 11 givenname: Ruixi surname: Yu fullname: Yu, Ruixi organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 12 givenname: Qiang surname: Cao fullname: Cao, Qiang organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 13 givenname: Pengchao surname: Li fullname: Li, Pengchao organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University – sequence: 14 givenname: Xueying surname: Sun fullname: Sun, Xueying organization: Department of Radiology, The First Affiliated Hospital of Nanjing Medical University – sequence: 15 givenname: Yuan surname: Zou fullname: Zou, Yuan organization: Department of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics – sequence: 16 givenname: Xue surname: Fu fullname: Fu, Xue organization: Department of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics – sequence: 17 givenname: Xiangming surname: Fang fullname: Fang, Xiangming email: xiangming_fang@njmu.edu.cn organization: Department of Radiology, Wuxi Medical Center of Nanjing Medical University – sequence: 18 givenname: Chunxiao surname: Chen fullname: Chen, Chunxiao email: ccxbme@nuaa.edu.cn organization: Department of Biomedical Engineering, Nanjing University of Aeronautics and Astronautics – sequence: 19 givenname: Qiang surname: Lu fullname: Lu, Qiang email: doctorlvqiang@njmu.edu.cn organization: Department of Urology, The First Affiliated Hospital of Nanjing Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40121216$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks9vFCEUx4mpsbX2H_BgSLx4GeXXMODFmPprkyZeajySN8zbLZtZWGFmk_73sru1th6EA_D4vC88-D4nJzFFJOQlZ285k-ZdUby1pmFCNUZYZhv5hJwJptpGSCFOHsxPyUUpa1ZbK6zi9hk5VYyL2vUZ6T8hbumIkGOIK5oivRY_F3RKdJtxCH6i0w3SzVz8iE2IOyhhh7QfYRgwUw_RY35PoRLjFBqPcdqHxxCDh5GWaR5uX5CnSxgLXtyN5-THl8_Xl9-aq-9fF5cfrxqvrJoaKXRnWuH14I20moERioHqgQF0ZhAdGGZ8P7Sy7W1dC9F5lAaWyjLJZC_PyeKoOyRYu20OG8i3LkFwh0DKKwd5CrUQpw1yDoAtSKk809Aj6CVHo3wHg_JV68NRazv3Gxz2dWUYH4k-3onhxq3SznFuhe1sWxXe3Cnk9GvGMrlNKB7HESKmuTjJDdNGS80q-vofdJ3mHOtbHSihheW2Uq8eXun-Ln_-sgLiCPicSsm4vEc4c3vPuKNnXPWMO3jGyZokj0mlwnGF-e_Z_8n6DTSqws4 |
Cites_doi | 10.3748/wjg.v27.i18.2122 10.1016/j.eururo.2019.08.032 10.1088/1361-6560/ac25d5 10.1109/CVPR.2016.308 10.1016/j.clgc.2020.03.002 10.1016/j.eururo.2021.02.021 10.1016/j.media.2023.102799 10.1016/j.eururo.2020.03.055 10.1016/S2589-7500(20)30078-9 10.3389/fonc.2021.704039 10.1186/s13073-021-00968-x 10.1002/mp.15646 10.3390/diagnostics12071601 10.1186/s40644-020-00304-3 10.1148/radiol.2019182506 10.1016/j.eururo.2018.04.029 10.1038/s41591-019-0536-x 10.1007/s00330-020-06796-8 10.1016/j.ejrad.2021.109666 10.1109/TBME.2020.2993528 10.1016/S0140-6736(19)32998-8 10.1007/s00330-022-09272-7 10.3322/caac.21660 10.1159/000443185 10.21037/tau.2020.02.16 10.1016/j.euf.2021.05.005 10.1111/iju.14748 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). Copyright Nature Publishing Group 2025 The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: Copyright Nature Publishing Group 2025 – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41598-024-82909-3 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Science Database Biological science database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_68e11aae5a334c06abea6f1e84c7ad4c PMC11929795 40121216 10_1038_s41598_024_82909_3 |
Genre | Multicenter Study Journal Article |
GrantInformation_xml | – fundername: Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project grantid: JSPH-MC-2021–15, JSPH-MA-2022–5 – fundername: Jiangsu Province Capability Improvement Project through Science,Technology and Education grantid: NO.ZDXK202219 – fundername: National Natural Science Foundation of China grantid: 82072832, 82273152 – fundername: Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project grantid: JSPH-MC-2021-15, JSPH-MA-2022-5 |
GroupedDBID | 0R~ 4.4 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD AASML ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AFPKN AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M1P M2P M7P M~E NAO OK1 PHGZT PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM UKHRP AAYXX CITATION PHGZM SNYQT CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 88A 8FK AARCD K9. M48 PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c494t-3267852c6dc83960a8240a4ba0aa78d27a808cbd535b98d2227ce38af490303b3 |
IEDL.DBID | DOA |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:27:03 EDT 2025 Thu Aug 21 18:40:07 EDT 2025 Thu Jul 10 22:00:13 EDT 2025 Wed Aug 13 08:08:04 EDT 2025 Mon Jul 21 05:34:53 EDT 2025 Tue Jul 01 05:18:19 EDT 2025 Sun Mar 23 01:28:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Deep learning MIBC MRI Bladder cancer |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-3267852c6dc83960a8240a4ba0aa78d27a808cbd535b98d2227ce38af490303b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/68e11aae5a334c06abea6f1e84c7ad4c |
PMID | 40121216 |
PQID | 3180262919 |
PQPubID | 2041939 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_68e11aae5a334c06abea6f1e84c7ad4c pubmedcentral_primary_oai_pubmedcentral_nih_gov_11929795 proquest_miscellaneous_3180686360 proquest_journals_3180262919 pubmed_primary_40121216 crossref_primary_10_1038_s41598_024_82909_3 springer_journals_10_1038_s41598_024_82909_3 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-03-22 |
PublicationDateYYYYMMDD | 2025-03-22 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2025 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | J Yu (82909_CR17) 2022; 49 JA Witjes (82909_CR2) 2021; 79 H Min (82909_CR13) 2021 J Li (82909_CR16) 2023; 33 C Vente (82909_CR8) 2021; 68 Y Yang (82909_CR20) 2021; 139 82909_CR28 RT Bryan (82909_CR5) 2021; 80 H Wang (82909_CR25) 2019; 291 KA Tran (82909_CR12) 2021; 13 M Marchioni (82909_CR23) 2020; 18 S Liu (82909_CR26) 2020; 9 H Sung (82909_CR1) 2021; 71 G Zhang (82909_CR15) 2021; 11 S Cackowski (82909_CR27) 2023; 88 D Ardila (82909_CR9) 2019; 25 B Yuan (82909_CR22) 2022; 29 X Xu (82909_CR4) 2021; 11 M Kozikowski (82909_CR19) 2022; 8 Z Wang (82909_CR24) 2020; 20 V Panebianco (82909_CR6) 2018; 74 D D’Agostino (82909_CR3) 2016; 97 82909_CR18 E Shkolyar (82909_CR14) 2019; 76 PP Wang (82909_CR7) 2021; 27 OJ Skrede (82909_CR11) 2020; 395 H Wang (82909_CR21) 2020; 30 KL Liu (82909_CR10) 2020; 2 |
References_xml | – volume: 27 start-page: 2122 year: 2021 ident: 82909_CR7 publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v27.i18.2122 – volume: 76 start-page: 714 year: 2019 ident: 82909_CR14 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2019.08.032 – year: 2021 ident: 82909_CR13 publication-title: Phys. Med. Biol. doi: 10.1088/1361-6560/ac25d5 – ident: 82909_CR18 doi: 10.1109/CVPR.2016.308 – volume: 18 start-page: 409 year: 2020 ident: 82909_CR23 publication-title: Clin. Genitourin. Cancer doi: 10.1016/j.clgc.2020.03.002 – volume: 80 start-page: 12 year: 2021 ident: 82909_CR5 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2021.02.021 – volume: 88 start-page: 102799 year: 2023 ident: 82909_CR27 publication-title: Med. Image Anal. doi: 10.1016/j.media.2023.102799 – volume: 79 start-page: 82 year: 2021 ident: 82909_CR2 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2020.03.055 – volume: 2 start-page: e303 year: 2020 ident: 82909_CR10 publication-title: Lancet Digit Health doi: 10.1016/S2589-7500(20)30078-9 – volume: 11 start-page: 704039 year: 2021 ident: 82909_CR4 publication-title: Front. Oncol. doi: 10.3389/fonc.2021.704039 – volume: 13 start-page: 152 year: 2021 ident: 82909_CR12 publication-title: Genome Med. doi: 10.1186/s13073-021-00968-x – volume: 11 start-page: 65468510 year: 2021 ident: 82909_CR15 publication-title: Front. Oncol. – volume: 49 start-page: 4622 year: 2022 ident: 82909_CR17 publication-title: Med. Phys. doi: 10.1002/mp.15646 – ident: 82909_CR28 doi: 10.3390/diagnostics12071601 – volume: 20 start-page: 26 year: 2020 ident: 82909_CR24 publication-title: Cancer Imaging doi: 10.1186/s40644-020-00304-3 – volume: 291 start-page: 668 year: 2019 ident: 82909_CR25 publication-title: Radiology doi: 10.1148/radiol.2019182506 – volume: 74 start-page: 294 year: 2018 ident: 82909_CR6 publication-title: Eur. Urol. doi: 10.1016/j.eururo.2018.04.029 – volume: 25 start-page: 1319 year: 2019 ident: 82909_CR9 publication-title: Nat. Med. doi: 10.1038/s41591-019-0536-x – volume: 30 start-page: 4816 year: 2020 ident: 82909_CR21 publication-title: Eur. Radiol. doi: 10.1007/s00330-020-06796-8 – volume: 139 start-page: 109666 year: 2021 ident: 82909_CR20 publication-title: Eur. J. Radiol. doi: 10.1016/j.ejrad.2021.109666 – volume: 68 start-page: 374 year: 2021 ident: 82909_CR8 publication-title: IEEE Trans. Biomed. Eng. doi: 10.1109/TBME.2020.2993528 – volume: 395 start-page: 350 year: 2020 ident: 82909_CR11 publication-title: Lancet doi: 10.1016/S0140-6736(19)32998-8 – volume: 33 start-page: 2699 year: 2023 ident: 82909_CR16 publication-title: Eur. Radiol. doi: 10.1007/s00330-022-09272-7 – volume: 71 start-page: 209 year: 2021 ident: 82909_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21660 – volume: 97 start-page: 54 year: 2016 ident: 82909_CR3 publication-title: Urol. Int. doi: 10.1159/000443185 – volume: 9 start-page: 445 year: 2020 ident: 82909_CR26 publication-title: Transl. Androl. Urol. doi: 10.21037/tau.2020.02.16 – volume: 8 start-page: 728 year: 2022 ident: 82909_CR19 publication-title: Eur. Urol. Focus doi: 10.1016/j.euf.2021.05.005 – volume: 29 start-page: 186 year: 2022 ident: 82909_CR22 publication-title: Int. J. Urol. doi: 10.1111/iju.14748 |
SSID | ssj0000529419 |
Score | 2.443381 |
Snippet | To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients in our... Abstract To develop a deep learning (DL) model based on MRI to predict muscle-invasive bladder cancer (MIBC). A total of 559 patients, including 521 patients... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 9942 |
SubjectTerms | 631/67/2321 631/67/589 Accuracy Adult Aged Aged, 80 and over Bladder cancer Cancer Deep Learning Female Humanities and Social Sciences Humans Invasiveness Magnetic Resonance Imaging - methods Male MIBC Middle Aged MRI multidisciplinary Neoplasm Invasiveness Predictive Value of Tests Science Science (multidisciplinary) Urinary Bladder - diagnostic imaging Urinary Bladder - pathology Urinary Bladder Neoplasms - diagnostic imaging Urinary Bladder Neoplasms - pathology |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9QwDI5gERIXxJsuCwoSN4i2TdI04YJ4rRYkOO2KuUVpki4rQTt0Oivx77HTzKyG17F5SK7t2FbsfCbkWc11B55Ms-C9YRJ8DHPcGRZlV0H4aqRP7YA-fVbHp_Ljol7kC7dVLqvc2MRkqMPg8Y78UCBUmeKmMq-WPxh2jcLsam6hcZVcQ-gy1Opm0WzvWDCLJSuT38qUQh-uwF_hmzIuGWYQDRM7_ijB9v8t1vyzZPK3vGlyR0e3yM0cR9LXs-Bvkyuxv0Ouz50lf94l7bsYlzS3hDijQ09P-JcPdBrocsTUzEQh8KPf1yvYzM77C4dV7LT9hnZopB5VYXxJHU31hgzJweH8ipImTNp75PTo_cnbY5bbKTAPPJ8YBGqNrrlXwUNUpEqnwZs72brSuUYH3jhdat-GWtStgW_OGx-Fdp00YAlEK-6TvX7o40NCYXMITvAYIaIJLujOKN1EAf6_EXXZFuT5hql2OaNm2JTtFtrOIrAgAptEYEVB3iDftysR8ToNDOOZzQfIKh2ryrlYOyGkL5Vro1NdFTVokwvSF-RgIzWbj-HKXipNQZ5up-EAYVbE9XFYz2uURti0gjyYhbylRCLiHa9UQfSO-HdI3Z3pz78mkG7QR24aUxfkxUZTLun6Ny_2__8bj8gNjg2IS8E4PyB707iOjyEqmtonSfV_ASgLCYM priority: 102 providerName: ProQuest – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VVkhcEG8CBRmJG1gktuPY3JZHVVaCC63oLZo4TqkEySqbrdR_z9hJFi2UA8f4IY08Y8-nzMw3AC9zYRryZIbXzlmuyMdwFGi5V01G8NUqF9sBff6ij0_V8iw_2wMx18LEpP1IaRmf6Tk77M2aHE0oBhOKh9Cf5fIGHASqdrLtg8Vi-XW5_bMSYlcqs1OFTCrNNZt3vFAk678OYf6dKPlHtDQ6oaM7cHtCj2wxynsX9nx7D26O_SSv7kP1wfsVmxpBnLOuZSfi2yc2dGzVh4DMwAjusZ-bNW3mF-0lhtx1Vv0Ir0_PXDCA_i1DFrMMeRAnDE-1kywy0T6A06OPJ--P-dREgTs66YETPCtMLpyuHWEhnaIhH46qwhSxMLUo0KTGVXUu88rStxCF89Jgoyzdf1nJh7Dfdq1_DIw21zVK4T3hmBpr01htCi_J6xcyT6sEXs2HWq5GrowyxrilKUcVlKSCMqqglAm8C-e-XRl4ruNA15-Xk95LbXyWIfocpVQu1Vh51E3mDdkQ1solcDhrrZwu37qUgdVOC5vZBF5sp-nahFgItr7bjGu0CWRpCTwalbyVRAWeO5HpBMyO-ndE3Z1pL75Hau6MALMtbJ7A69lSfsv177N48n_Ln8ItEdoQp5ILcQj7Q7_xzwgbDdXz6TL8AiP6CMA priority: 102 providerName: Springer Nature |
Title | Deep learning on T2WI to predict the muscle-invasive bladder cancer: a multi-center clinical study |
URI | https://link.springer.com/article/10.1038/s41598-024-82909-3 https://www.ncbi.nlm.nih.gov/pubmed/40121216 https://www.proquest.com/docview/3180262919 https://www.proquest.com/docview/3180686360 https://pubmed.ncbi.nlm.nih.gov/PMC11929795 https://doaj.org/article/68e11aae5a334c06abea6f1e84c7ad4c |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED_BEBIviG8CozISb2AtsR3H5q0rm0YlJgSb6Ft0cZwxCdKqTZH47zk7aVn5EC88RfFHdLo7-37R2b8DeJEL01AkM7x2znJFMYajQMu9ajKCr1a5WA7o3ak-OVfTWT67UuornAnr6YF7xR1o47MM0ecopXKpxsqjbjJv6CtYKxd2X4p5V36melZvYVVmh1syqTQHK4pU4TaZUDzkDi2XO5EoEvb_CWX-fljyl4xpDETHd-D2gCDZuJf8Llzz7T242deU_H4fqjfeL9hQDOKCzVt2Jj69Zd2cLZYhKdMxgnzs63pFk_ll-w3D-XVWfQk70JK54ATL1wxZPGnIgzihebg_ySIb7QM4Pz46m5zwoZACd6TtjhNEK0wunK4d4SGdoqE4jqrCFLEwtSjQpMZVdS7zytK7EIXz0mCjLO0BspIPYa-dt_4xMJpc1yiF94RlaqxNY7UpvKTIX8g8rRJ4uVFquej5MsqY55am7E1QkgnKaIJSJnAY9L4dGbiuYwN5QDl4QPkvD0hgf2O1cliAq1IGZjstbGYTeL7tpqUT8iHY-vm6H6NNIExL4FFv5K0kKnDdiUwnYHbMvyPqbk97-TnSc2cEmm1h8wRebTzlp1x_18WT_6GLp3BLhALFqeRC7MNet1z7Z4SaumoE14tZMYIb4_H045Seh0en7z9Q60RPRnHx_ADcPRhj |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgQXxJtAASPBCawmtpPYSAgBpdqlj9NW7M11HKdUgmTZzYL6p_iNjJ1kq-V16zF-JBPPjOezx54BeJYyWaElk7S0VlGBNoYaZhR1okoQviphQzqgg8NsdCQ-TtPpBvwc7sL4Y5XDnBgm6rKxfo98m_tQZRlTiXoz-0Z91ijvXR1SaHRisefOfuCSbfF6vIP8fc7Y7ofJ-xHtswpQi59uKeKVXKbMZqVFcJDFRqJRM6IwsTG5LFluZCxtUaY8LRQ-M5Zbx6WphEKF4AXH916Cy2h4Y7_Yy6f5ak_He81Eovq7OTGX2wu0j_4OGxPUeywV5Wv2L6QJ-Bu2_fOI5m9-2mD-dm_A9R63kredoN2EDVffgitdJsuz21DsODcjfQqKE9LUZMI-jUnbkNncu4JagkCTfF0usDM9rb8bf2qeFF_8vDcn1ove_BUxJJxvpJ4cX9zf2iQhBu4dOLqQgb4Lm3VTu_tAsHNZGs6cQwRVmlJWKpO544g3cp7GRQQvhkHVsy5Khw7edS51xwKNLNCBBZpH8M6P-6qlj7AdCpr5ie4VVmfSJYkxLjWcCxtnpnAmqxInUXpNKWwEWwPXdK_2C30upBE8XVWjwnovjKlds-zaZNKHaYvgXsfkFSXCR9hjSRaBXGP_GqnrNfXp5xAUPEGornKVRvBykJRzuv49Fg_-_xtP4OpocrCv98eHew_hGvPJj2NOGduCzXa-dI8QkbXF46AGBI4vWu9-AZRDRPY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTiBeEN8EBhgJnsBqYjuJjYQQo6tWBtWENrE3z3GcMQmS0qag_Wv8dZzz0al8ve0xjh1dfHe-n33nO4CnMZMFWjJJc2sVFWhjqGFGUSeKCOGrErYpB_RhmuweindH8dEG_Ozvwviwyn5NbBbqvLL-jHzIfaqyhKlIDYsuLGJ_NH49-0Z9BSnvae3LabQisufOfuD2bfFqMkJeP2NsvHPwdpd2FQaoRTJqitgllTGzSW4RKCShkWjgjMhMaEwqc5YaGUqb5TGPM4XPjKXWcWkKoVA5eMbxu5dgM_W7ogFsbu9M9z-uTni8D01EqrupE3I5XKC19DfamKDef6koX7OGTdGAvyHdPwM2f_PaNsZwfB2udSiWvGnF7gZsuPImXG7rWp7dgmzk3Ix0BSlOSFWSA_ZpQuqKzObeMVQThJ3k63KBg-lp-d34GHqSffGr4JxYL4jzl8SQJtqRenJ8c3eHkzQZcW_D4YVM9R0YlFXp7gHBwXluOHMO8VRuclmoRKaOI_pIeRxmATzvJ1XP2pwduvG1c6lbFmhkgW5YoHkA237eVz19vu2moZqf6E59dSJdFBnjYsO5sGFiMmeSInISZdnkwgaw1XNNd4vAQp-LbABPVq9Rfb1PxpSuWrZ9EumTtgVwt2XyihLh8-2xKAlArrF_jdT1N-Xp5yZFeITAXaUqDuBFLynndP17Lu7__zcewxXUOf1-Mt17AFeZr4QccsrYFgzq-dI9RHhWZ486PSBwfNGq9wtrNEqR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deep+learning+on+T2WI+to+predict+the+muscle-invasive+bladder+cancer%3A+a+multi-center+clinical+study&rft.jtitle=Scientific+reports&rft.au=Cai%2C+Lingkai&rft.au=Yang%2C+Xiao&rft.au=Yu%2C+Jie&rft.au=Shao%2C+Qiang&rft.date=2025-03-22&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-024-82909-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41598_024_82909_3 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |